Hmm next 3 months should also include the Giardia and Endometriosis POC results I would have thought considering the last update indicated the concepts were now being finalized.
These are two massive catalysts for PIQ as they will move into clinical trials if the POC is realized...
Perhaps he was keeping the answers focused on PromarkerD specifically.
It sounds like even Richard has been a bit put back on his expectations on getting the test out into the public, it's certainly taking much longer than they first anticipated.
I really wish we could get some more transparency on where the commercialization is in current state, how many hospitals is it available in, what volume are they expecting, what's been invoiced so far from DR, how is the Mexico and Spain rollout going, whats holding back the US partner, etc etc
Perhaps I am too anxious and need to trust things are unfolding positively ..
I guess it's all a matter of perspective, it's tax loss selling month and PIQ could go back down to 24/6c quite easily. Good news if you want to buy more, and we should have some news come early FY20 just in time when the market heats up so could see a very strong rally on a solid announcement.
So got to stay positive, one things for sure is the annual report will be positive given the strong quarterly revenue results we had this year vs py.
BRING HER HOME RICHARD!!!
PIQ Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)